Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Market capitalisation, EUR | 11,529 m |
| EPS, EUR | -1.55 |
| P/B ratio | 22.1 |
| P/E ratio | - |
| Dividend yield | 0.00% |
| Revenue, EUR | 652 m |
| Net income, EUR | -420 m |
| Profit margin | -64.37% |
| ETF | Poids | Objectif d'investissement | Taille fonds en M € |
|---|---|---|---|
| JPMorgan Active US Value UCITS ETF USD (acc) | 0.11% | Equity United States Value | 62 |
| JPMorgan Active US Value UCITS ETF EUR Hedged (acc) | 0.11% | Equity United States Value | 4 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 1.04% | Equity United States Health Care Biotech | 46 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% | Equity World Social/Environmental | 491 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Distributing | 0.02% | Equity North America Social/Environmental | 24 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.20% | Equity United States Small Cap | 190 |
| JPMorgan Active US Value UCITS ETF USD (dist) | 0.11% | Equity United States Value | 6 |
| Année en cours | +0,04% |
| 1 mois | -0,61% |
| 3 mois | +13,09% |
| 6 mois | +84,36% |
| 1 an | +133,98% |
| 3 ans | +84,21% |
| 5 ans | +43,98% |
| Depuis la création (MAX) | +8,02% |
| 2025 | +99,32% |
| 2024 | -25,48% |
| 2023 | +30,77% |
| 2022 | +29,46% |
| Volatilité 1 an | 52,72% |
| Volatilité 3 ans | 42,22% |
| Volatilité 5 ans | 42,57% |
| Rendement par risque 1 an | 2,54 |
| Rendement par risque 3 ans | 0,53 |
| Rendement par risque 5 ans | 0,18 |
| Perte maximale sur 1 an | -27,29% |
| Perte maximale sur 3 ans | -52,33% |
| Perte maximale sur 5 ans | -52,33% |
| Perte maximale depuis la création | -74,00% |